TILs Characterization Flow Cytometry

Affiches Jun 9, 2018
Cytométrie en flux

June 9, 2018

Karen K. Yam¹, Stephen Parker², Michael Agrez², Christopher Warburton¹, Adriana Alcantara¹, Vicky Sgouroudis¹, and Jean-Francois Poulin¹. ¹Caprion Biosciences Inc., Montreal, Quebec, Canada. ²Inter-K Peptide Therapeutics, New South Wales, Australia

Characterization of Two Potential Immunotherapeutics in Tumor Infiltrating Lymphocytes (TILs) Using Flow Cytometry and Meso Scale Discovery, ASCO 2018

Characterization of Two Potential Immunotherapeutics in Tumor Infiltrating Lymphocytes (TILs) Using Flow Cytometry and Meso Scale Discovery

Featured Resources

See All Experts' Insights
Header 3 1024x341 Blogue
Jun 30, 2026

B-Cell Monitoring in Autoimmune Programs: Expert Insights | CellCarta
Header 1024x341 Blogue
Jun 30, 2026

CAR Kinetics in Autoimmune Studies: Expert Insights on Designing Effective Monitoring Strategies | CellCarta
Header 2 1024x341 Blogue
Jun 30, 2026

Designing T-Cell Activation and Exhaustion Assays for Autoimmune Programs: Expert Insights | CellCarta
See All Experts' Insights

One global CRO for your whole therapeutic development journey

CellCarta has the multi-modal capabilities, scientific depth, and harmonized global footprint needed to advance even the most complex programs in precision medicine.

Talk to our Team
cta banner